Industry: Chemical & Material
Published Date: 2025-02-14
Pages: 91 Pages
Report ld: 3785775
Request Sample
Customized Report
Pharmaceutical Active and Intelligent Packaging Market Size(US$)

CAGR 2025-2031
9%
Market Size,2031
USD 111,390
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Active and Intelligent Packaging market size was US$ 61440 million in 2024 and is forecast to a readjusted size of US$ 111390 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Pharmaceutical Active and Intelligent Packaging market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Active and Intelligent Packaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmaceutical Active and Intelligent Packaging in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Pharmaceutical Active and Intelligent Packaging manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Active and Intelligent Packaging revenue, gross margin, and recent development, etc.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Active Packaging
1.2.3 Intelligent Packaging
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Human Medicine
1.3.3 Veterinary Medicine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Active and Intelligent Packaging Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Region (2020-2025)
2.4 Global Pharmaceutical Active and Intelligent Packaging Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Pharmaceutical Active and Intelligent Packaging Market Size and Prospective (2020-2031)
2.5.2 Europe Pharmaceutical Active and Intelligent Packaging Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Market Size and Prospective (2020-2031)
2.5.4 Latin America Pharmaceutical Active and Intelligent Packaging Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Pharmaceutical Active and Intelligent Packaging Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Pharmaceutical Active and Intelligent Packaging Historic Market Size by Type (2020-2025)
3.2 Global Pharmaceutical Active and Intelligent Packaging Forecasted Market Size by Type (2026-2031)
3.3 Different Types Pharmaceutical Active and Intelligent Packaging Representative Players
4 Breakdown Data by Application
4.1 Global Pharmaceutical Active and Intelligent Packaging Historic Market Size by Application (2020-2025)
4.2 Global Pharmaceutical Active and Intelligent Packaging Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Active and Intelligent Packaging Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Pharmaceutical Active and Intelligent Packaging Players by Revenue (2020-2025)
5.1.2 Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Pharmaceutical Active and Intelligent Packaging Revenue
5.4 Global Pharmaceutical Active and Intelligent Packaging Market Concentration Analysis
5.4.1 Global Pharmaceutical Active and Intelligent Packaging Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Active and Intelligent Packaging Revenue in 2024
5.5 Global Key Players of Pharmaceutical Active and Intelligent Packaging Head office and Area Served
5.6 Global Key Players of Pharmaceutical Active and Intelligent Packaging, Product and Application
5.7 Global Key Players of Pharmaceutical Active and Intelligent Packaging, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Pharmaceutical Active and Intelligent Packaging Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2025)
6.1.2.2 North America Pharmaceutical Active and Intelligent Packaging Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2025)
6.1.3.2 North America Pharmaceutical Active and Intelligent Packaging Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2025)
6.2.2.2 Europe Pharmaceutical Active and Intelligent Packaging Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2025)
6.2.3.2 Europe Pharmaceutical Active and Intelligent Packaging Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Pharmaceutical Active and Intelligent Packaging Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2025)
6.4.2.2 Latin America Pharmaceutical Active and Intelligent Packaging Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2025)
6.4.3.2 Latin America Pharmaceutical Active and Intelligent Packaging Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Pharmaceutical Active and Intelligent Packaging Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Pharmaceutical Active and Intelligent Packaging Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Pharmaceutical Active and Intelligent Packaging Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 BASF
7.1.1 BASF Company Details
7.1.2 BASF Business Overview
7.1.3 BASF Pharmaceutical Active and Intelligent Packaging Introduction
7.1.4 BASF Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.1.5 BASF Recent Development
7.2 Amcor
7.2.1 Amcor Company Details
7.2.2 Amcor Business Overview
7.2.3 Amcor Pharmaceutical Active and Intelligent Packaging Introduction
7.2.4 Amcor Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.2.5 Amcor Recent Development
7.3 Honeywell International
7.3.1 Honeywell International Company Details
7.3.2 Honeywell International Business Overview
7.3.3 Honeywell International Pharmaceutical Active and Intelligent Packaging Introduction
7.3.4 Honeywell International Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.3.5 Honeywell International Recent Development
7.4 Landec
7.4.1 Landec Company Details
7.4.2 Landec Business Overview
7.4.3 Landec Pharmaceutical Active and Intelligent Packaging Introduction
7.4.4 Landec Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.4.5 Landec Recent Development
7.5 Bemis Company
7.5.1 Bemis Company Company Details
7.5.2 Bemis Company Business Overview
7.5.3 Bemis Company Pharmaceutical Active and Intelligent Packaging Introduction
7.5.4 Bemis Company Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.5.5 Bemis Company Recent Development
7.6 Crown Holdings
7.6.1 Crown Holdings Company Details
7.6.2 Crown Holdings Business Overview
7.6.3 Crown Holdings Pharmaceutical Active and Intelligent Packaging Introduction
7.6.4 Crown Holdings Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.6.5 Crown Holdings Recent Development
7.7 Ball Corporation
7.7.1 Ball Corporation Company Details
7.7.2 Ball Corporation Business Overview
7.7.3 Ball Corporation Pharmaceutical Active and Intelligent Packaging Introduction
7.7.4 Ball Corporation Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.7.5 Ball Corporation Recent Development
7.8 Sonoco Products
7.8.1 Sonoco Products Company Details
7.8.2 Sonoco Products Business Overview
7.8.3 Sonoco Products Pharmaceutical Active and Intelligent Packaging Introduction
7.8.4 Sonoco Products Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.8.5 Sonoco Products Recent Development
7.9 Graphic Packaging
7.9.1 Graphic Packaging Company Details
7.9.2 Graphic Packaging Business Overview
7.9.3 Graphic Packaging Pharmaceutical Active and Intelligent Packaging Introduction
7.9.4 Graphic Packaging Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.9.5 Graphic Packaging Recent Development
7.10 Timestrip UK
7.10.1 Timestrip UK Company Details
7.10.2 Timestrip UK Business Overview
7.10.3 Timestrip UK Pharmaceutical Active and Intelligent Packaging Introduction
7.10.4 Timestrip UK Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.10.5 Timestrip UK Recent Development
7.11 Coveris Holdings
7.11.1 Coveris Holdings Company Details
7.11.2 Coveris Holdings Business Overview
7.11.3 Coveris Holdings Pharmaceutical Active and Intelligent Packaging Introduction
7.11.4 Coveris Holdings Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.11.5 Coveris Holdings Recent Development
7.12 Sealed Air Corporation
7.12.1 Sealed Air Corporation Company Details
7.12.2 Sealed Air Corporation Business Overview
7.12.3 Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Introduction
7.12.4 Sealed Air Corporation Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.12.5 Sealed Air Corporation Recent Development
7.13 Dessicare
7.13.1 Dessicare Company Details
7.13.2 Dessicare Business Overview
7.13.3 Dessicare Pharmaceutical Active and Intelligent Packaging Introduction
7.13.4 Dessicare Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.13.5 Dessicare Recent Development
7.14 WestRock Company
7.14.1 WestRock Company Company Details
7.14.2 WestRock Company Business Overview
7.14.3 WestRock Company Pharmaceutical Active and Intelligent Packaging Introduction
7.14.4 WestRock Company Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.14.5 WestRock Company Recent Development
7.15 CCL Industrie
7.15.1 CCL Industrie Company Details
7.15.2 CCL Industrie Business Overview
7.15.3 CCL Industrie Pharmaceutical Active and Intelligent Packaging Introduction
7.15.4 CCL Industrie Revenue in Pharmaceutical Active and Intelligent Packaging Business (2020-2025)
7.15.5 CCL Industrie Recent Development
8 Pharmaceutical Active and Intelligent Packaging Market Dynamics
8.1 Pharmaceutical Active and Intelligent Packaging Industry Trends
8.2 Pharmaceutical Active and Intelligent Packaging Market Drivers
8.3 Pharmaceutical Active and Intelligent Packaging Market Challenges
8.4 Pharmaceutical Active and Intelligent Packaging Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharmaceutical Active and Intelligent Packaging was estimated to be worth US$ 66420 million in 2025 and is projected to reach US$ 120420 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 106
USD 3950.00
(Single User License)
The global Pharmaceutical Active and Intelligent Packaging market was valued at US$ 66420 million in 2025 and is anticipated to reach US$ 120420 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 117
USD 2900.00
(Single User License)
The global Pharmaceutical Active and Intelligent Packaging market is projected to grow from US$ 61440 million in 2024 to US$ 111390 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-03
Pages: 145
USD 4900.00
(Single User License)
The global market for Pharmaceutical Active and Intelligent Packaging was estimated to be worth US$ 61440 million in 2024 and is forecast to a readjusted size of US$ 111390 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 116
USD 3950.00
(Single User License)
The global market for Pharmaceutical Active and Intelligent Packaging was valued at US$ 61440 million in the year 2024 and is projected to reach a revised size of US$ 111390 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published Date: 2025-02-14
Pages: 86
USD 2900.00
(Single User License)
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published Date: 2024-04-11
Pages: 117
USD 4900.00
(Single User License)
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published Date: 2024-02-21
Pages: 91
USD 2900.00
(Single User License)
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published Date: 2024-01-04
Pages: 125
USD 3950.00
(Single User License)
The global market for Pharmaceutical Active and Intelligent Packaging was estimated to be worth US$ 66420 million in 2025 and is projected to reach US$ 120420 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-02-01
Pages: 106
The global Pharmaceutical Active and Intelligent Packaging market was valued at US$ 66420 million in 2025 and is anticipated to reach US$ 120420 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-02-01
Pages: 117
The global Pharmaceutical Active and Intelligent Packaging market is projected to grow from US$ 61440 million in 2024 to US$ 111390 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 145
The global market for Pharmaceutical Active and Intelligent Packaging was estimated to be worth US$ 61440 million in 2024 and is forecast to a readjusted size of US$ 111390 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 116
The global market for Pharmaceutical Active and Intelligent Packaging was valued at US$ 61440 million in the year 2024 and is projected to reach a revised size of US$ 111390 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published: 2025-02-14
Pages: 86
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published: 2024-04-11
Pages: 117
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published: 2024-02-21
Pages: 91
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published: 2024-01-04
Pages: 125
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now